Allurion Technologies Inc. (ALUR)
OQB · Healthcare · Medical Devices
$1.15
-1.71%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.2M
Shares Outstanding
1.0M
P/S (TTM)
0.1x
Exchange
OQB
Currency
USD
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 3.4M | 2.7M | 3.6M | 2.9M |
| Gross Profit | 2.5M | 1.3M | 1.6M | 1.2M |
| Operating Income | (7.0M) | (9.6M) | (6.3M) | (3.7M) |
| Net Income | (9.3M) | (11.9M) | (6.0M) | (6.1M) |
| Diluted EPS | $-1.28 | $-1.53 | N/A | $-0.46 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 64.2M | 53.5M | 32.1M | 15.2M |
| Gross Profit | 50.7M | 41.5M | 21.5M | 9.6M |
| Operating Income | (32.0M) | (79.1M) | (50.2M) | (30.2M) |
| Net Income | (37.7M) | (82.8M) | (7.2M) | (28.8M) |
| Diluted EPS | $-21.85 | $-57.75 | $-11.64 | $-3.81 |